Alerts will be sent to your verified email
Verify EmailARTEMISMED
Artemis Medicare
|
Beta Drugs
|
Zenotech Laboratorie
|
|
---|---|---|---|
Operational Metrics
|
|||
Hospital Sector
|
|||
Average Daily Revenue Per Occupied Bed
|
79200.0 Rs | n/a | n/a |
Hospital Occupancy Rate
|
66.6 % | n/a | n/a |
Average Length Of Stay
|
3.6 Days | n/a | n/a |
Unclassified
|
|||
Number of Surgeries - Quarterly
|
3708.0 . | n/a | n/a |
Number of Outpatient Visits - Quarterly
|
97049.0 . | n/a | n/a |
Financials
|
|||
5 yr Average ROE
|
7.55 % | 21.02 % | 7.83 % |
5yr average Equity Multiplier
|
2.07 | 1.82 | 1.26 |
5yr Average Asset Turnover Ratio
|
0.81 | 0.97 | 0.33 |
5yr Avg Net Profit Margin
|
4.33 % | 11.94 % | -17.58 % |
Price to Book
|
8.86 | 0.0 | 6.27 |
P/E
|
70.92 | 44.64 | 69.78 |
5yr Avg Cash Conversion Cycle
|
-108.41 Days | 4.72 Days | 36.89 Days |
Inventory Days
|
6.72 Days | 40.73 Days | 145.01 Days |
Days Receivable
|
39.07 Days | 86.71 Days | 61.38 Days |
Days Payable
|
166.71 Days | 110.62 Days | 477.06 Days |
5yr Average Interest Coverage Ratio
|
3.17 | 11.36 | -4.03 |
5yr Avg ROCE
|
8.78 % | 25.44 % | 7.95 % |
5yr Avg Operating Profit Margin
|
12.74 % | 21.55 % | 12.81 % |
5 yr average Debt to Equity
|
0.48 | 0.31 | 0.12 |
5yr CAGR Net Profit
|
19.95 % | 30.75 % | n/a |
5yr Average Return on Assets
|
3.58 % | 11.68 % | 7.07 % |
Shareholdings
|
|||
Promoter Holding
|
67.51 % | 66.73 % | 68.84 % |
Share Pledged by Promoters
|
44.53 % | 0.0 | 0.0 |
Change in Promoter Holding (3 Yrs)
|
-2.31 % | 0.05 % | 0.0 |
Change in Mutual Fund Holding (3 Yrs)
|
1.23 % | 0.0 | 0.0 |
Artemis Medicare
|
Beta Drugs
|
Zenotech Laboratorie
|
|
---|---|---|---|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
-
|
Therapeutic Area Break-Up
|
Therapeutic Area Break-Up
|
-
|
-
|
Asset Break-Up - Geography Wise
|
Asset Break-Up - Geography Wise
|
-
|
-
|